Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cameron

Showing results (1341-1350 of 1,485) with videos related to

Pageof 149
Sort By:
World Journal of Surgery|July 21, 2022
Postoperative Chemotherapy is Associated with Improved Survival in Patients with Node-Positive Pancreatic Ductal Adenocarcinoma After Neoadjuvant TherapyGabriel D Ivey, Sami Shoucair, Daniel J Delitto, et al.
Annals of Surgery|September 16, 2022
A Delay in Adjuvant Therapy Is Associated With Worse Prognosis Only in Patients With Transitional Circulating Tumor Cells After Resection of Pancreatic Ductal AdenocarcinomaAmmar A Javed, Anne Floortje van Oosten, Joseph R Habib, et al.
World Journal of Surgery|January 7, 2022
Accurate Nodal Staging in Pancreatic Cancer in the Era of Neoadjuvant TherapyAmmar A Javed, Ding Ding, Erum Baig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activationE M Jaffee, R H Hruban, B Biedrzycki, et al.
Annals of Surgery|June 18, 2025
The Mutational Status of Driver Genes in Patients with Resected Pancreatic Ductal Adenocarcinoma is Associated with Pathological Characteristics and Overall SurvivalBrady A Campbell, Dario Solinas, Amanda L Blackford, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 23, 2006
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experienceJordan M Winter, John L Cameron, Kurtis A Campbell, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 8, 2012
Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancerCharles C Hsu, Christopher L Wolfgang, Daniel A Laheru, et al.
Annals of Surgery|January 16, 2018
Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer?Jin He, Alex B Blair, Vincent P Groot, et al.
Annals of Surgery|November 17, 2020
Invasive and Noninvasive Progression After Resection of Noninvasive Intraductal Papillary Mucinous NeoplasmsNeda Amini, Joseph R Habib, Alex Blair, et al.
BMJ Open Sport & Exercise Medicine|May 7, 2026
Sex, but not exposure-related variables, predicts baseline serum glial fibrillar acidic protein and neurofilament light levels in contact sport athletesMelissa Anderson, Caitlin A Gallo, Scott W Passalugo, et al.
Pageof 149

Showing results (1341-1350 of 1,485) with videos related to

Sort By:
Pageof 149
World Journal of Surgery|July 21, 2022
Postoperative Chemotherapy is Associated with Improved Survival in Patients with Node-Positive Pancreatic Ductal Adenocarcinoma After Neoadjuvant TherapyGabriel D Ivey, Sami Shoucair, Daniel J Delitto, et al.
Annals of Surgery|September 16, 2022
A Delay in Adjuvant Therapy Is Associated With Worse Prognosis Only in Patients With Transitional Circulating Tumor Cells After Resection of Pancreatic Ductal AdenocarcinomaAmmar A Javed, Anne Floortje van Oosten, Joseph R Habib, et al.
World Journal of Surgery|January 7, 2022
Accurate Nodal Staging in Pancreatic Cancer in the Era of Neoadjuvant TherapyAmmar A Javed, Ding Ding, Erum Baig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activationE M Jaffee, R H Hruban, B Biedrzycki, et al.
Annals of Surgery|June 18, 2025
The Mutational Status of Driver Genes in Patients with Resected Pancreatic Ductal Adenocarcinoma is Associated with Pathological Characteristics and Overall SurvivalBrady A Campbell, Dario Solinas, Amanda L Blackford, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 23, 2006
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experienceJordan M Winter, John L Cameron, Kurtis A Campbell, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 8, 2012
Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancerCharles C Hsu, Christopher L Wolfgang, Daniel A Laheru, et al.
Annals of Surgery|January 16, 2018
Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer?Jin He, Alex B Blair, Vincent P Groot, et al.
Annals of Surgery|November 17, 2020
Invasive and Noninvasive Progression After Resection of Noninvasive Intraductal Papillary Mucinous NeoplasmsNeda Amini, Joseph R Habib, Alex Blair, et al.
BMJ Open Sport & Exercise Medicine|May 7, 2026
Sex, but not exposure-related variables, predicts baseline serum glial fibrillar acidic protein and neurofilament light levels in contact sport athletesMelissa Anderson, Caitlin A Gallo, Scott W Passalugo, et al.
Pageof 149